WEDNESDAY, Oct. 30, 2024 -- An exercise intervention can effectively reduce alcohol dependence in patients with alcohol use disorder (AUD), according...

FRIDAY, Oct. 25, 2024 -- For patients with opioid use disorder (OUD) and alcohol use disorder (AUD), prescriptions of glucose-dependent insulinotropic...

A late-stage study shows that Novo Nordisk's oral semaglutide, Rybelsus, cuts the risk of MACE by 14% in T2D patients compared to placebo.

Ozempic and other GLP-1 drugs show promise not only in managing obesity and diabetes but also in reducing Alzheimer's risk. A study published in...

TUESDAY, Oct. 22, 2024 -- Patients with early rheumatoid arthritis (RA) have a high incidence of prevalent and incident hypertension, according to a...

A protein that is involved in determining which enzymes cut or unwind DNA during the replication process has been identified in a new study. In a new...

Israeli researchers were surprised to find that alcohol use, as compared to psychedelics, contributed more significantly to psychological challenges...

THURSDAY, Oct. 31, 2024 -- For individuals with obesity and knee osteoarthritis, once-weekly semaglutide yields greater reductions in body weight and...

New research from Harvard University suggests that Mars might have been habitable more recently than scientists previously believed. The study,...

A recent study published in Nature Communications has uncovered how our brains handle fear memories in two contradictory ways: making it hard to...